Items per page
Sort by

Send to:

Choose Destination

Results: 14

Cited In for PubMed (Select 15518609)


Association of antidiabetic medications targeting the glucagon-like peptide 1 pathway and heart failure events in patients with diabetes.

Velez M, Peterson EL, Wells K, Swadia T, Sabbah HN, Williams LK, Lanfear DE.

J Card Fail. 2015 Jan;21(1):2-8. doi: 10.1016/j.cardfail.2014.10.012. Epub 2014 Oct 28.


Race and association of angiotensin converting enzyme/angiotensin receptor blocker exposure with outcome in heart failure.

El-Refai M, Hrobowski T, Peterson EL, Wells K, Spertus JA, Williams LK, Lanfear DE.

J Cardiovasc Med (Hagerstown). 2014 May 16. [Epub ahead of print]


Relationship of Loop Diuretic Dosing and Acute Changes in Renal Function during Hospitalization for Heart Failure.

El-Refai M, Krivospitskaya O, Peterson EL, Wells K, Williams LK, Lanfear DE.

J Clin Exp Cardiolog. 2011 Nov 22;2(10). pii: 1000164.


Gender differences in the etiology of heart failure: A systematic review.

Azad N, Kathiravelu A, Minoosepeher S, Hebert P, Fergusson D.

J Geriatr Cardiol. 2011 Mar;8(1):15-23. doi: 10.3724/SP.J.1263.2011.00015.


Comparison of renal predictors for in-hospital and postdischarge mortality after hospitalized heart failure.

Singh G, Peterson EL, Wells K, Williams LK, Lanfear DE.

J Cardiovasc Med (Hagerstown). 2012 Apr;13(4):246-53. doi: 10.2459/JCM.0b013e3283516767.


A systematic review of validated methods for identifying heart failure using administrative data.

Saczynski JS, Andrade SE, Harrold LR, Tjia J, Cutrona SL, Dodd KS, Goldberg RJ, Gurwitz JH.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:129-40. doi: 10.1002/pds.2313. Review.


Association of β-blocker exposure with outcomes in heart failure differs between African American and white patients.

Lanfear DE, Hrobowski TN, Peterson EL, Wells KE, Swadia TV, Spertus JA, Williams LK.

Circ Heart Fail. 2012 Mar 1;5(2):202-8. doi: 10.1161/CIRCHEARTFAILURE.111.965780. Epub 2012 Jan 19.


Relation of worsened renal function during hospitalization for heart failure to long-term outcomes and rehospitalization.

Lanfear DE, Peterson EL, Campbell J, Phatak H, Wu D, Wells K, Spertus JA, Williams LK.

Am J Cardiol. 2011 Jan;107(1):74-8. doi: 10.1016/j.amjcard.2010.08.045.


The heart failure epidemic.

Roger VL.

Int J Environ Res Public Health. 2010 Apr;7(4):1807-30. doi: 10.3390/ijerph7041807. Epub 2010 Apr 19. Review.


Comparing methods for identifying patients with heart failure using electronic data sources.

Alqaisi F, Williams LK, Peterson EL, Lanfear DE.

BMC Health Serv Res. 2009 Dec 18;9:237. doi: 10.1186/1472-6963-9-237.


Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.

Habib ZA, Tzogias L, Havstad SL, Wells K, Divine G, Lanfear DE, Tang J, Krajenta R, Pladevall M, Williams LK.

Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):437-47. doi: 10.1002/pds.1722.


Patient sex does not modify ejection fraction as a predictor of death in heart failure: insights from the APPROACH cohort.

Schmaltz HN, Southern DA, Maxwell CJ, Knudtson ML, Ghali WA; APPROACH Investigators.

J Gen Intern Med. 2008 Dec;23(12):1940-6. doi: 10.1007/s11606-008-0804-9. Epub 2008 Oct 2.


Impact of adherence to statins on chronic heart failure in primary prevention.

Perreault S, Dragomir A, Blais L, Bérard A, Lalonde L, White M.

Br J Clin Pharmacol. 2008 Nov;66(5):706-16. doi: 10.1111/j.1365-2125.2008.03269.x. Epub 2008 Jul 24.


A comprehensive view of sex-specific issues related to cardiovascular disease.

Pilote L, Dasgupta K, Guru V, Humphries KH, McGrath J, Norris C, Rabi D, Tremblay J, Alamian A, Barnett T, Cox J, Ghali WA, Grace S, Hamet P, Ho T, Kirkland S, Lambert M, Libersan D, O'Loughlin J, Paradis G, Petrovich M, Tagalakis V.

CMAJ. 2007 Mar 13;176(6):S1-44. Review. Erratum in: CMAJ. 2007 Apr 24;176(9):1310.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk